Lv1
30 积分 2024-06-06 加入
The resurgence of covalent drugs
2天前
已完结
Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy
8个月前
已完结
Repurposing AS1411 for constructing ANM-PROTACs
9个月前
已完结
Structure-based, deep-learning models for protein-ligand binding affinity prediction
10个月前
已完结
Reversible Michael Additions: Covalent Inhibitors and Prodrugs
10个月前
已完结
皖公网安备34019202002308
